Solutions For Healthcare Providers
Improve Patient Care and Satisfaction
Syndromic infectious disease testing from BioFire can help healthcare providers enhance patient management with fast, accurate, and comprehensive results.
Eliminate the Guesswork with the BioFire® FilmArray® System
Traditional infectious disease diagnostics leaves many infections undiagnosed, leading to downstream testing and procedures, compromised care, and patient dissatisfaction.
The BioFire System performs syndromic PCR tests that detect infectious agents at the molecular level. With a revolutionary syndromic approach and the broadest target menu on the market, the BioFire® FilmArray® Panels empower healthcare providers to choose the right test, the first time.
Get Better Results Faster
Syndromic testing takes the guesswork out of choosing which pathogens to test for. Requiring just one patient sample and one rapid test, the BioFire System uses multiplex PCR technology to provide accurate pathogen identification on a comprehensive target menu.
With a turnaround time of about an hour, a BioFire Panel test can provide the actionable answers that physicians need to make vital patient management decisions with confidence. It is more sensitive than culture and more efficient than serial testing and increases the probability of identifying a pathogen in patients with symptoms of an infectious disease.
Be An Antimicrobial Steward
As part of an Antimicrobial Stewardship Program, the BioFire System can help healthcare providers reduce the number of unnecessary and inappropriate antibiotic prescriptions with fast answers on a broad grouping of pathogens and antimicrobial resistance genes.
Actionable answers in a clinically relevant timeframe can also help physicians optimize antimicrobial therapy sooner for patients with life-threatening conditions like sepsis and meningitis.
Confront COVID-19 and Other Respiratory Season Pathogens
SARS-CoV-2 remains a top concern for physicians and patients alike. BioFire brought its syndromic approach to COVID-19 testing to help healthcare providers quickly rule in—and rule out—common causes of respiratory illness.
The BioFire FilmArray Panels
The BioFire System is easy to use, from integrated sample preparation to automated results analysis. Each of the syndromic infectious disease panels on the BioFire System targets a comprehensive grouping of targets associated with a clinical syndrome.
BioFire® Respiratory 2.1 (RP2.1) Panel
Respiratory infections are difficult to diagnose based on symptoms alone. In about 45 minutes, the BioFire RP2.1 Panel targets 22 pathogens including SARS-CoV-2, influenza, and RSV in a single test.
BioFire® Respiratory 2.1-EZ (RP2.1-EZ) Panel (EUA)
Now FDA Emergency Use Authorized, the BioFire RP2.1-EZ Panel is designed to be used in near-patient settings, providing a rapid and comprehensive alternative to targeted send-out tests.
BioFire® Blood Culture Identification 2 (BCID2) Panel
To aid in the early identification of sepsis, the BioFire BCID2 Panel tests for 43 targets associated with bloodstream infections, including gram-negative and gram-positive bacteria, yeast, and antimicrobial resistance genes.
BioFire® FilmArray® Gastrointestinal (GI) Panel
Traditional stool testing can be slow and lack sensitivity. The BioFire GI Panel requires just one patient sample and about an hour to test for 22 of the most common bacterial, viral, and parasitic causes of infectious gastroenteritis.
BioFire® FilmArray® Meningitis/Encephalitis (ME) Panel
The BioFire ME Panel can help healthcare providers distinguish between bacterial and viral meningitis. One test identifies 14 bacteria, viruses, and fungi associated with meningitis/encephalitis in about an hour.
BioFire® FilmArray® Pneumonia (PN) Panel
By testing for 33 pathogens in about an hour, the BioFire PN Panel can help healthcare providers optimize therapy faster. Semi-quantitative results on 15 bacteria may help determine whether an organism is a colonizer or a pathogen.
BioFire® Joint Infection (JI) Panel*
Now under FDA review, the BioFire JI Panel has a potential target menu of 39 bacteria, yeast, and antimicrobial resistance genes that commonly cause difficult-to-diagnose joint infections.
*Investigational use only. Not for sale. BioFire JI Panel menu subject to change.
What Healthcare Providers Are Saying
See how multiplex PCR testing from BioFire is helping healthcare providers diagnose infections faster, optimize antimicrobial therapy, and make informed patient care decisions at their facilities.
BioFire® Syndromic Trends (Trend)
BioFire Trend is a cloud-based software feature from BioFire customers that provides local and regional pathogen circulation trends on demand. BioFire Trend visualizes de-identified respiratory and gastrointestinal pathogen data detected by select US customers running BioFire System tests.
BioFire Trend demonstrates the possibility of achieving the goal of comprehensive real-time monitoring of infectious disease prevalence while still preserving patient privacy.
Request a BioFire FilmArray System Demo
Are you ready to order the BioFire FilmArray System or want to request a free demo? Click below to take the next step towards faster results. Our team is ready to answer all of your questions.